Gunnar Gunnarsson
Kristianstad University College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gunnar Gunnarsson.
PLOS ONE | 2010
Elsa Jourdain; Gunnar Gunnarsson; John Wahlgren; Neus Latorre-Margalef; Caroline Bröjer; Sofie Sahlin; Lovisa Svensson; Jonas Waldenström; Åke Lundkvist; Björn Olsen
Wild waterfowl, particularly dabbling ducks such as mallards (Anas platyrhynchos), are considered the main reservoir of low-pathogenic avian influenza viruses (LPAIVs). They carry viruses that may evolve and become highly pathogenic for poultry or zoonotic. Understanding the ecology of LPAIVs in these natural hosts is therefore essential. We assessed the clinical response, viral shedding and antibody production of juvenile mallards after intra-esophageal inoculation of two LPAIV subtypes previously isolated from wild congeners. Six ducks, equipped with data loggers that continually monitored body temperature, heart rate and activity, were successively inoculated with an H7N7 LPAI isolate (day 0), the same H7N7 isolate again (day 21) and an H5N2 LPAI isolate (day 35). After the first H7N7 inoculation, the ducks remained alert with no modification of heart rate or activity. However, body temperature transiently increased in four individuals, suggesting that LPAIV strains may have minor clinical effects on their natural hosts. The excretion patterns observed after both re-inoculations differed strongly from those observed after the primary H7N7 inoculation, suggesting that not only homosubtypic but also heterosubtypic immunity exist. Our study suggests that LPAI infection has minor clinically measurable effects on mallards and that mallard ducks are able to mount immunological responses protective against heterologous infections. Because the transmission dynamics of LPAIVs in wild populations is greatly influenced by individual susceptibility and herd immunity, these findings are of high importance. Our study also shows the relevance of using telemetry to monitor disease in animals.
PLOS ONE | 2011
Josef D. Järhult; Shaman Muradrasoli; John Wahlgren; Hanna Söderström; Goran Orozovic; Gunnar Gunnarsson; Caroline Bröjer; Neus Latorre-Margalef; Jerker Fick; Roman Grabic; Johan Lennerstrand; Jonas Waldenström; Åke Lundkvist; Bjørn Magne Olsen
Oseltamivir (Tamiflu®) is the most widely used drug against influenza infections and is extensively stockpiled worldwide as part of pandemic preparedness plans. However, resistance is a growing problem and in 2008–2009, seasonal human influenza A/H1N1 virus strains in most parts of the world carried the mutation H274Y in the neuraminidase gene which causes resistance to the drug. The active metabolite of oseltamivir, oseltamivir carboxylate (OC), is poorly degraded in sewage treatment plants and surface water and has been detected in aquatic environments where the natural influenza reservoir, dabbling ducks, can be exposed to the substance. To assess if resistance can develop under these circumstances, we infected mallards with influenza A/H1N1 virus and exposed the birds to 80 ng/L, 1 µg/L and 80 µg/L of OC through their sole water source. By sequencing the neuraminidase gene from fecal samples, we found that H274Y occurred at 1 µg/L of OC and rapidly dominated the viral population at 80 µg/L. IC50 for OC was increased from 2–4 nM in wild-type viruses to 400–700 nM in H274Y mutants as measured by a neuraminidase inhibition assay. This is consistent with the decrease in sensitivity to OC that has been noted among human clinical isolates carrying H274Y. Environmental OC levels have been measured to 58–293 ng/L during seasonal outbreaks and are expected to reach µg/L-levels during pandemics. Thus, resistance could be induced in influenza viruses circulating among wild ducks. As influenza viruses can cross species barriers, oseltamivir resistance could spread to human-adapted strains with pandemic potential disabling oseltamivir, a cornerstone in pandemic preparedness planning. We propose surveillance in wild birds as a measure to understand the resistance situation in nature and to monitor it over time. Strategies to lower environmental levels of OC include improved sewage treatment and, more importantly, a prudent use of antivirals.
Royal Society of London. Proceedings B. Biological Sciences; 276(1666), pp 2347-2349 (2009) | 2009
Neus Latorre-Margalef; Gunnar Gunnarsson; Vincent J. Munster; R. A. M. Fouchier; Albert D. M. E. Osterhaus; Johan Elmberg; Björn Olsen; Anders Wallensten; Thord Fransson; Lars Brudin; Jonas Waldenström
[Flint & Franson (in press)][1] comment on our recent paper about influenza A virus in wild mallards ( Anas platyrhynchos ; [Latorre-Margalef et al . 2009][2]). They acknowledge the quality of our data and analyses, but think that our interpretation of the results is incomplete. One can break down
Svensk Jakt | 2011
Johan Elmberg; Gunnar Gunnarsson
Vår fågelvärld | 2010
Johan Elmberg; Gunnar Gunnarsson; Jonas Waldenström; Neus Latorre-Margalef; Björn Olsen
Svensk jakt: Svenska jägareförbundets tidskrift | 2010
Gunnar Gunnarsson; Johan Elmberg; Jonas Waldenström; Björn Olsen
Suomen Riista | 2010
Hannu Pöysä; Petri Nummi; Johan Elmberg; Gunnar Gunnarsson; Kjell Sjöberg
2nd Pan-European Duck Symposium, Arles, France 23-26 March 2009 | 2009
Gunnar Gunnarsson; Neus Latorre-Margalef; Vincent J. Munster; R. A. M. Fouchier; Albert Osterhaus; Johan Elmberg; Björn Olsen; Anders Wallensten; Paul D. Haemig; Thord Fransson; Lars Brudin; Jonas Waldenström
33rd IUGB Congress and 14th Perdix Congress 22-25 Aug, Montpellier | 2017
Hannu Pöysä; Johan Elmberg; Gunnar Gunnarsson; Sari Holopainen; Petri Nummi; Kjell Sjöberg
The 7th North American Duck Symposium (NADS7), Annapolis, Maryland, 1-5 February 2016 | 2016
Johan Elmberg; Pär Söderquist; Gunnar Gunnarsson; Carl-Gustaf Thulin; Jocelyn Champagnon; Matthieu Guillemain; Jakub Kreisinger; Herbert H. T. Prins; R.P.M.A. Crooijmans; Robert H. S. Kraus